Once‐Weekly Insulin Efsitora Alfa Versus Once Daily Insulin in Patients With Type 2 Diabetes: A Systematic Review and Meta‐Analysis
ABSTRACT Background Once‐daily basal insulin is widely used in the management of type 2 diabetes, but poor adherence to daily injections often impairs glycaemic control. Once‐weekly efsitora alfa may overcome these limitations, but pooled data assessing its comparative efficacy and safety remain lim...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Wiley
2025-11-01
|
| Reeks: | Endocrinology, Diabetes & Metabolism |
| Onderwerpen: | |
| Online toegang: | https://doi.org/10.1002/edm2.70126 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|
